🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was intended to assess the safety, efficacy, and response to tre...
Status
Completed
Location
Novartis Investigative site
Start Date
2007-05
Trial ID
NCT00504595
Treatments Being Tested
The 24-week, dose-ranging, multi-center, double-blind, double-dummy, active...
Status
Completed
Location
Talbert Medical Group
Start Date
2008-12
Trial ID
NCT00819585
Treatments Being Tested
The purpose of this study was to demonstrate that canakinumab given upon ac...
Status
Completed
Location
Pinnacle Research Group, LLC
Start Date
2010-03
Trial ID
NCT01080131
This study assessed the safety and efficacy of canakinumab pre-filled syrin...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-05
Trial ID
NCT01356602
Treatments Being Tested
This two-part study assessed the sustained efficacy of canakinumab in the d...
Status
Completed
Location
Arkansas Children's Hospital Research Inst
Start Date
2009-07
Trial ID
NCT00889863
Treatments Being Tested
This study assessed the initial efficacy and safety of canakinumab over a 4...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2009-07
Trial ID
NCT00886769
Treatments Being Tested
The purpose of the 12-week core study was to demonstrate that canakinumab g...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-12
Trial ID
NCT01029652
This study was intended to evaluate the safety and efficacy of intravenous ...
Status
Completed
Location
Rheumatology Associates of Northern Alabama (Dr. William Shergy)
Start Date
2007-03
Trial ID
NCT00487825
Treatments Being Tested